Why Jennifer Doudna is one of Fast Company’s 10 most innovative people of the last 10 years
When biochemist Jennifer Doudna and her research partner, Emmanuelle Charpentier, published a paper in Science 12 years ago, ...
The Times of Israel on MSN9d
Israeli researchers use gene editing to eliminate 50% of head, neck tumors in mice
Tel Aviv University scientists say that they can inject CRISPR genetic 'molecular scissors' to shrink tumors by 90%; ...
Fast Company1y
Jennifer Doudna
Tory Burch and Nobel Prize winner Jennifer Doudna are teaming up to help women scientists The entrepreneur and the biochemist speak exclusively with "Fast Company" about a new fellowship that ...
University of California6d
Discoveries that changed the world: Meet UC’s women Nobel laureates
If Andrea Ghez had listened to her critics, one of the galaxy’s greatest mysteries might yet remain unsolved. The UCLA astronomer won the 2020 Nobel Prize in physics for proving the existence of a ...
KQED19d
UC Berkeley Scientists Protest Trump Administration’s Cuts to Research Funding
Jennifer Doudna speaks at a rally at UC Berkeley in association with the national Stand Up for Science day of action in Berkeley on March 7, 2025. (Martin do Nascimento/KQED) NIH, the largest ...
The Scientist4y
CRISPR’s Adaptation to Genome Editing Earns Chemistry Nobel
Emmanuelle Charpentier and Jennifer Doudna reprogrammed the bacterial immune response into one of the most popular tools for genetics and molecular biology. Amanda was an associate editor at The ...
Local News Matters on MSN17d
Changing the climate on science: Nationwide movement pushes back on cuts for research
AT University of California Berkeley’s Sproul Plaza, a spot famous for student activism, it was the professors’ turn to protest. Nearly 2,000 scientists, Nobel laureates, student researchers and ...
The Scientist5mon
From CRISPR to Prime Editing: The Evolution of the Genome Editing Revolution
Scientists realized that they could edit and disrupt gene ... it may also lead to unintended chromosomal loss in the edited immune cells. Biochemist Jennifer Doudna and her team at the University of ...
Hosted on MSN1mon
Tempus AI director Jennifer Doudna sells $118,800 in stock
Jennifer Doudna, a director at Tempus AI , Inc. (NASDAQ:TEM), recently sold a portion of her holdings in the company. According to a recent SEC filing, Doudna sold 1,320 shares of Tempus AI's ...